Plain-English translation of NCT04604041 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →Researchers are looking for hidden markers—early warning signs that show up in brain activity, nerve function, and blood—that might help detect multiple sclerosis before symptoms appear or worsen. This study compares people with relapsing-remitting multiple sclerosis who are on different treatments with healthy volunteers to understand what these markers reveal about the disease.
Currently, doctors rely on symptoms and visible changes on MRI scans to diagnose and monitor multiple sclerosis. This research aims to find earlier, hidden clues in the nervous system and immune system that could help catch disease activity sooner and guide better treatment decisions.
You likely qualify if…
You likely don't qualify if…
You would visit the research center for clinical and neurological examinations. You would receive a brain MRI scan and specialized nerve stimulation tests that measure how your brain and nerves respond. You would also complete memory and thinking tests, and provide blood samples for laboratory analysis. The exact number and timing of visits would depend on which treatment group you're in, but the study involves comparing people on different MS treatments with healthy controls.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Croatia